At MyEyesAI, we believe that timely access to eye care should be universal. The global shortage of ophthalmologists leaves millions of patients underserved, forcing delays in diagnosis and treatment that can result in irreversible vision loss. We are here to change that.
Founded at the intersection of medicine, AI, and healthcare innovation, MyEyesAI’s mission is to bridge the gap between patients and ophthalmology expertise using real-time, multimodal artificial intelligence. We recognize the urgent need for healthcare systems, communities, and frontline providers to access reliable, accurate, and affordable specialty support—anytime, anywhere.
4 Principles
Our work is guided by four principles:
Accuracy you can trust – AI trained and validated for ophthalmology.
Access for all – From large hospitals to rural clinics, to ERs and even disaster zones.
Seamless integration – Into workflows, EHRs, and telehealth systems.
Vision first – Democratizing access to ophthalmology, instant decison support and educational tool for clinicians and patients.
Leadership
co-Founder & Chief Medical Information Officer (CMIO), MyEyesAI
Carl Rosen, MA, MD, MPA
Dr. Carl Rosen is a pioneering ophthalmologist and healthcare innovator whose expertise spans orbital surgery, neuro-ophthalmology, and oculoplastic care. Since joining Ophthalmic Associates in 1994, he has become Alaska’s first and only board-certified, fellowship-trained orbital and oculoplastic surgeon, as well as the state’s only board-certified, fellowship-trained neuro-ophthalmologist.
He holds degrees from Amherst College (BA, cum laude), Harvard University (MA in Immunology), Boston University School of Medicine (MD), and an MPA from Harvard Kennedy School. Dr. Rosen completed his ophthalmology residency at Albert Einstein College of Medicine, followed by a fellowship in oculoplastics, orbital surgery, and neuro-ophthalmology at Allegheny General Hospital. He also completed the Stanford GSB LEAD Program.
Throughout his career, Dr. Rosen has published in leading medical journals, authored a book chapter on Graves’ Orbitopathy, and received research awards in the field. He is a fellow of the American Academy of Ophthalmology, an inductee to ASOPRS (American Society for Oculoplastic and Reconstructive Surgeons), and has served as president of both the Alaska Ophthalmology Society and the Alaska State Medical Association.
Dr. Rosen is also a successful entrepreneur, with a previous leadership role as CEO of CallDR, an innovative healthcare venture that exited successfully. Beyond medicine, he is a black belt in Brazilian Jiu-Jitsu, an award-winning competitor, a classical music enthusiast, and a lifelong innovator at the crossroads of healthcare and technology.
co-Founder & Chief Executive Officer (CEO), MyEyesAI
Rohit Mahajan
Rohit Mahajan is a recognized leader in healthcare technology and AI transformation, bringing decades of experience scaling enterprises and developing cutting-edge digital health solutions. He serves as CEO and Managing Partner of Damo Consulting and BigRio, both leading firms in AI, generative AI, and data-driven innovation for healthcare, life sciences, and payers.
He is the host of The Big Unlock Podcast, a globally respected platform for healthcare AI and digital transformation, co-hosted with Ritu M. Uberoy. Rohit’s career includes leadership roles at Wipro and IBM, where he honed global delivery expertise. He is also involved in multiple ventures and advisory roles, including Managing Partner at C2R Tech, and Founder of BetterLungs.
A lifelong learner, Rohit holds a Bachelor’s degree in Electronics and Communications Engineering, is a Wharton Fellow, and has completed programs at Harvard Business School, MIT Sloan, MIT CSAIL, and Harvard School of Public Health, with a focus on AI in business and healthcare. He also completed the Global Healthcare Leaders Program at Harvard Medical School.
He is the author of Quantum Care: A Deep Dive into AI for Health Delivery and Research, a best-selling book on AI in healthcare that has trended #1 in multiple Amazon categories. Beyond authorship, Rohit actively contributes to conferences, podcasts, and advisory boards, shaping the global conversation on AI-driven healthcare.
Passionate about innovation, entrepreneurship, and digital health equity, Rohit brings the vision, strategy, and execution focus to make MyEyesAI a transformative force in specialty care delivery.
Chief AI Officer, MyEyesAI
Ritu M. Uberoy
Ritu is the Managing Partner at BigRio and Damo Consulting. She has over 25 years of experience in the software and information technology industry in the United States and in India. She has been involved in the delivery of several successful software projects and products to clients across diverse industry segments.
Ritu completed AI for Health Care: Concepts and Applications from the Harvard T.H. Chan School of Public Health and Applied Generative AI for Digital Transformation from MIT Professional Education. She also received the Human Centered AI Leadership Certificate from AI Powered Women@MIT and completed the Harvard Alumni Entrepreneurs Product Market Fit program.
She has successfully delivered GenAI and Agentic AI concepts in webinars and workshop settings to C-Suite leaders in Houston, Boston, and Cleveland. She attended HIMSS in March 2024 and 2025 and the Imagination in Action AI Summit at MIT in April 2024. She also leads the GenAI Center of Excellence at BigRio and the AI Maturity Model and Assessment at Damo.
Ritu earned her Bachelor’s degree in Computer Science from Delhi Institute of Technology (now NSIT) and a Master’s degree in Computer Science from Santa Clara University in California. She has participated in the Fellow’s Program at The Wharton School, University of Pennsylvania
Advisor, Telemedicine
Chris Gallagher, MD
As a cardiologist in rural Texas hospitals, Dr. Gallagher noticed that timely care was one of the most important variables in a favorable patient outcome. However, this was not happening consistently across hospitals. So, he started looking for a virtual solution that could ensure the delivery of high-quality, timely care.
When he didn’t find it, he built it.
As founder of Access TeleCare, the nation’s largest high-acuity telemedicine provider, Dr. Gallagher brought his experience in internal medicine and cardiology to pave the way for tech-enabled clinical networks. Today, Access TeleCare is the standard bearer of excellence in telemedicine, a 2024 Top Remote Workplace, operating virtual care programs in all 50 states across 8 medical specialties, with a virtual catchment area of over 216 million Americans (across 15,000+ zip codes) representing roughly 65% of the U.S. population.
In his role as Chief Strategy Officer, Dr. Gallagher drives innovation, identifies strategic partnerships, and plans for the company’s strategic growth.
Dr. Gallagher trained at UT Southwestern for his Internal Medicine Residency and Cardiology Fellowship and earned his Doctor of Medicine from Texas Tech University School of Medicine.
Advisor
Cathy Cohen
Catherine Cohen is a results-driven Government Relations executive with years of proven success in delivering innovative solutions to policy problems for specialty physicians and medical device companies. After 25 years heading the Washington office for the American Academy of Ophthalmology, she recently launched a consulting business — Strategies for Innovative Policy Solutions — to continue working on Medicare and Medicaid issues for disruptive technologies such as Artificial Intelligence and Remote Therapeutic Monitoring.
Catherine has an illustrious career, formerly a long time VP and more recently Senior Advisor to the American Academy of Ophthalmology. Before that, she was Director of Federal Affairs for Eastman Kodak and Director (D.C. office) of the American Society of Clinical Pathologists.
Catherine is a holder of many degrees and certificates, including Master’s Degree (MHSA), Health Policy and Administration from The George Washington University, Certified Association Executive, and Associative Management from American Society of Associations Executives, Senior Managers in Government Program, Policy and Management from Harvard Kennedy School, and BA in Political Science/Asian Studies from Regis College.
AVP, Partnerships
Atticus Rosen
Atticus Rosen is the AVP of Partnerships at MyEyesAI, where he leads strategic relationship-building across partners, clients, and investors to support adoption and growth. He develops and manages partnership and client pipelines, coordinates meetings between investors and founders, and helps drive strategic initiatives from outreach to execution. Working cross-functionally with software development and finance strategy, Atticus translates external stakeholder needs into clear internal priorities, while strengthening MyEyesAI’s market narrative through research, positioning, and pitch-deck refinement.
Atticus studied at Bowdoin College and brings a strong execution and stakeholder-management background from political organizing on congressional and mayoral campaigns, along with experience at a political consulting and business firm. He also founded, self-funded, and operated a business in college—building practical skills in operating lean, moving fast, and taking full ownership of results.
Outside of work, Atticus plays piano, studies Japanese, travels, and stays active. In the summers, he also works commercial fishing for king crab—an experience that reinforces his comfort with high-stakes environments, teamwork, and disciplined execution.
Our Vision
We are building the world’s first AI platform that serves as a true ophthalmology partner—an accessible, trustworthy, and expert resource that empowers clinicians, patients, and healthcare systems alike. With the combined leadership of Dr. Carl Rosen’s clinical excellence and Rohit Mahajan’s digital healthcare expertise, MyEyesAI is uniquely positioned to change the way the world sees.
Email
info@myeyesai.com
Address
245 Main Street, 2nd floor, Cambridge, MA 02142
© 2026 MyEyesAI, Inc. | Privacy Policy